<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0047)http://ontology.buffalo.edu/06/AMIAWorkshop.htm -->
<HTML xmlns="http://www.w3.org/TR/REC-html40" xmlns:v = 
"urn:schemas-microsoft-com:vml" xmlns:o = 
"urn:schemas-microsoft-com:office:office" xmlns:w = 
"urn:schemas-microsoft-com:office:word" xmlns:st1 = 
"urn:schemas-microsoft-com:office:smarttags"><HEAD><TITLE>The ability to measure patient information at the genomic level and its utility for stratifying clinically responsive groups is driving the next generation of drug therapies</TITLE>
<META http-equiv=Content-Type content="text/html; charset=windows-1252" /><LINK 
href="file:///C:\Documents%20and%20Settings\All%20Users\Documents\Eudora\attach\AMIA_Workshop_2006_LGC2.doc" 
rel=Original-File />
<META content=Word.Document name=ProgId />
<META content="MSHTML 6.00.2900.2963" name=GENERATOR />
<META content="Microsoft Word 10" name=Originator /><LINK 
href="AMIA_Workshop_2006_LGC2_files/filelist.xml" rel=File-List /><o:SmartTagType 
namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="country-region" 
downloadurl="http://www.5iantlavalamp.com/"></o:SmartTagType><o:SmartTagType 
namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="State" 
downloadurl="http://www.5iamas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType 
namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="City" 
downloadurl="http://www.5iamas-microsoft-com:office:smarttags"></o:SmartTagType><o:SmartTagType 
namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="place" 
downloadurl="http://www.5iantlavalamp.com/"></o:SmartTagType><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Anand Kumar</o:Author>
  <o:LastAuthor>Barry Smith</o:LastAuthor>
  <o:Revision>65</o:Revision>
  <o:TotalTime>224</o:TotalTime>
  <o:Created>2006-07-13T09:59:00Z</o:Created>
  <o:LastSaved>2006-07-14T11:28:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>653</o:Words>
  <o:Characters>3723</o:Characters>
  <o:Company>GSF Forschungszentrum</o:Company>
  <o:Lines>31</o:Lines>
  <o:Paragraphs>8</o:Paragraphs>
  <o:CharactersWithSpaces>4368</o:CharactersWithSpaces>
  <o:Version>10.2625</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:View>Print</w:View>
  <w:Zoom>BestFit</w:Zoom>
  <w:DontDisplayPageBoundaries/>
  <w:GrammarState>Clean</w:GrammarState>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if !mso]>
<OBJECT id=ieooui classid=clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D></OBJECT>
<STYLE>st1\:* {
	BEHAVIOR: url(#ieooui)
}
</STYLE>
<![endif]-->
<STYLE>
@font-face {
	font-family: Wingdings;
}
@font-face {
	font-family: Tahoma;
}
@page Section1 {size: 612.1pt 792.1pt; margin: 70.9pt 70.9pt 2.0cm 70.9pt; mso-header-margin: 35.45pt; mso-footer-margin: 35.45pt; mso-paper-source: 0; }
P.MsoNormal {
	FONT-SIZE: 12pt; MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman"; mso-style-parent: ""; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: DE
}
LI.MsoNormal {
	FONT-SIZE: 12pt; MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman"; mso-style-parent: ""; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: DE
}
DIV.MsoNormal {
	FONT-SIZE: 12pt; MARGIN: 0cm 0cm 0pt; FONT-FAMILY: "Times New Roman"; mso-style-parent: ""; mso-pagination: widow-orphan; mso-fareast-font-family: "Times New Roman"; mso-fareast-language: DE
}
A:link {
	COLOR: blue; TEXT-DECORATION: underline; text-underline: single
}
SPAN.MsoHyperlink {
	COLOR: blue; TEXT-DECORATION: underline; text-underline: single
}
A:visited {
	COLOR: purple; TEXT-DECORATION: underline; text-underline: single
}
SPAN.MsoHyperlinkFollowed {
	COLOR: purple; TEXT-DECORATION: underline; text-underline: single
}
SPAN.GramE {
	mso-style-name: ""; mso-gram-e: yes
}
DIV.Section1 {
	page: Section1
}
OL {
	MARGIN-BOTTOM: 0cm
}
UL {
	MARGIN-BOTTOM: 0cm
}
.style1 {font-family: Arial, Helvetica, sans-serif}
</STYLE>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";}
table.MsoTableGrid
	{mso-style-name:"Table Grid";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="2050"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]--></HEAD>
<BODY lang=EN-US style="tab-interval: 35.4pt" vLink=purple link=blue>
<DIV class=Section1>
<DIV align=center>
<TABLE class=MsoTableGrid 
style="BORDER-RIGHT: medium none; BORDER-TOP: medium none; BORDER-LEFT: medium none; BORDER-BOTTOM: medium none; BORDER-COLLAPSE: collapse; mso-border-alt: solid white .5pt; mso-yfti-tbllook: 480; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-border-insideh: .5pt solid white; mso-border-insidev: .5pt solid white" 
cellSpacing=0 cellPadding=0 border=1>
  <TBODY>
  <TR style="mso-yfti-irow: 0; mso-yfti-lastrow: yes">
    <TD 
    style="BORDER-RIGHT: white 1pt solid; PADDING-RIGHT: 14.2pt; BORDER-TOP: white 1pt solid; PADDING-LEFT: 14.2pt; PADDING-BOTTOM: 14.2pt; BORDER-LEFT: white 1pt solid; WIDTH: 481.1pt; PADDING-TOP: 14.2pt; BORDER-BOTTOM: white 1pt solid; mso-border-alt: solid white .5pt" 
    vAlign=top width=641>
      <P 
      align=center class=MsoNormal style1 style="TEXT-ALIGN: center; mso-outline-level: 1"><B style="mso-bidi-font-weight: normal"><SPAN 
      style="FONT-SIZE: 16pt">Toward Genomics Knowledge Representation for 
      Clinical Trials<o:p></o:p></SPAN></B></P>
      <P 
      align=center class=MsoNormal style1 style="TEXT-ALIGN: center; mso-outline-level: 1"><B style="mso-bidi-font-weight: normal"><SPAN 
      style="FONT-SIZE: 16pt">Workshop at <A 
      href="http://www.amia.org/meetings/f06/">2006 AMIA 
      Symposium</A><o:p></o:p></SPAN></B></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify; mso-outline-level: 1"><B 
      style="mso-bidi-font-weight: normal">Abstract</B></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify">The ability to measure 
      patient information at the genomic level and its utility for stratifying 
      clinically responsive groups is driving the next generation of drug 
      therapies. As a result, clinical trials are increasingly incorporating 
      molecular biology-based assays yielding genomic and proteomic data. 
      Effective management and analysis of this data requires knowledge 
      representation systems that span the biological and medical domains. For 
      this purpose, AMIA’s Genomics Working Group (GEN-WG), Knowledge 
      Representation Working Group (KR-WG), and Clinical Trials Working Group 
      (CT-WG) have collaborated to develop a workshop in an effort to exploit 
      the overlap between the three domains. </P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify; mso-outline-level: 1"><B 
      style="mso-bidi-font-weight: normal">Workshop Description</B></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify">We will begin with 
      presentations on biomedical ontologies and on the role they can play in 
      providing representation frameworks which can comprehend entities both at 
      the genomics and at the clinical levels of granularity. The key issues to 
      be discussed will be:</P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Differentiation between 
      continuant and occurrent entities </SPAN></P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Proper treatment of 
      fundamental relations in genomics</SPAN></P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l1 level1 lfo2; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>The ontology of clinical 
      trials</SPAN></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify">We will next discuss 
      several biological ontologies which should be used in conjunction with 
      <SPAN class=GramE>a clinical</SPAN> trial ontology to adequately represent 
      and analyze clinical trial data. We will focus on the ontological 
      representations of cells and proteins, and then explore the clinical 
      application of the resulting ontologies. Using as an example a large 
      case-control study of progression to sepsis after <I>Staph aureus 
      </I>infection, we will describe the role of the cell and protein 
      ontologies in interpreting the correlation between genomic and phenotypic 
      patient information and in identifying host susceptility genes. </P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify">We will then discuss how 
      systems for knowledge representation can in principle support reasoning 
      about alternative hypotheses, using as our test case the <A 
      href="http://www.hybrow.org/">HyBrow</A> system. The HyBrow (Hypothesis 
      Browser) system is a prototype tool for designing hypotheses and 
      evaluating them for consistency with existing knowledge. HyBrow consists 
      of a contradiction-based reasoning framework with the ability to reason 
      with diverse biological information, an ontology for composing hypotheses 
      about biological systems at different levels of granularity, a 
      knowledgebase to structure information according to the ontology, and 
      programs to design, evaluate and revise hypotheses. We will discuss how 
      such systems can be used to assist researchers in making sense of large 
      amounts of omic information.<o:p></o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify">We will then describe the 
      Immune Tolerance Network, a collaborative research effort that solicits, 
      develops, implements and evaluates clinical trials and related biological 
      assays for the purposes of inducing, maintaining and monitoring tolerance 
      in humans for kidney, liver and islet transplantation, autoimmune diseases 
      and allergy and asthma. The approach integrates phenotypic, molecular and 
      clinical data represented in context of the events and timings of the 
      specific study and based on the control ontology.</P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify">Finally, we will present 
      some applications of Grid technology for life sciences data integration 
      being used to integrate clinical genomics data to be used for clinical 
      trials especially within the framework of the EU-funded ACGT project on <A 
      href="http://www.eu-acgt.org/">Advancing Clinico-Genomics Trials</A>. </P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify; mso-outline-level: 1"><B 
      style="mso-bidi-font-weight: normal">Educational Goals</B>:</P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l0 level1 lfo3; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Role of knowledge 
      representation and formal ontologies in the field of clinical 
      genomics.</SPAN></P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l0 level1 lfo3; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Role of genomics data 
      management in clinical trials.</SPAN></P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l0 level1 lfo3; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Ontologies related to 
      clinical trials.</SPAN></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify; mso-outline-level: 1"><B 
      style="mso-bidi-font-weight: normal">Who should attend</B>:</P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify">AMIA attendees interested 
      in exploiting the overlap between the domains of Genomics, Knowledge 
      Representation and Clinical Trials.</P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify; mso-outline-level: 1"><B 
      style="mso-bidi-font-weight: normal">Speakers</B></P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l2 level1 lfo4; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Barry Smith (University at 
      </SPAN><st1:place><st1:City>Buffalo</st1:City>, <st1:State>NY</st1:State>, 
      <st1:country-region>USA</st1:country-region></st1:place> and <SPAN lang=DE 
      style="mso-ansi-language: DE">Institute for Formal Ontology and Medical 
      Information Science, </SPAN><st1:place><st1:City><SPAN lang=DE 
      style="mso-ansi-language: DE">Saarbrücken</SPAN></st1:City><SPAN lang=DE 
      style="mso-ansi-language: DE">, </SPAN><st1:country-region><SPAN lang=DE 
      style="mso-ansi-language: DE">Germany</SPAN></st1:country-region></st1:place>)</P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l2 level1 lfo4; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Lindsay Cowell 
      (</SPAN><st1:place><st1:City>Duke University</st1:City>, 
      <st1:State>NC</st1:State>, 
      <st1:country-region>USA</st1:country-region></st1:place>)</P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l2 level1 lfo4; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Nigam Shah 
      (</SPAN><st1:place><st1:City>Stanford University</st1:City>, 
      <st1:State>CA</st1:State>, 
      <st1:country-region>USA</st1:country-region></st1:place>)</P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l2 level1 lfo4; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      lang=IT 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: IT"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr><SPAN lang=IT 
      style="mso-ansi-language: IT">Dave Parrish (Immune Tolerance Network, PA, 
      USA)<o:p></o:p></SPAN></SPAN></P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l2 level1 lfo4; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Yannick Legre 
      (</SPAN><st1:place><st1:City>Healthgrid</st1:City>, 
      <st1:country-region>France</st1:country-region></st1:place>)</P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 
      style="TEXT-ALIGN: justify; mso-outline-level: 1"><B>Moderators
          <o:p></o:p>
      </B></P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l2 level2 lfo4"><![if !supportLists]><SPAN 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr>Werner Ceusters (University 
      at </SPAN><st1:place><st1:City>Buffalo</st1:City>, 
      <st1:State>NY</st1:State>, 
      <st1:country-region>USA</st1:country-region></st1:place>
      ) and Shawn Levy (Vanderbilt University, TN, USA) </P>
      <P class=MsoNormal style1 style="TEXT-ALIGN: justify"><o:p>&nbsp;</o:p></P>
      <P class=MsoNormal style1 
      style="TEXT-ALIGN: justify; mso-outline-level: 1"><B>Organizer</B> </P>
      <P class=MsoNormal style1 
      style="MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; TEXT-ALIGN: justify; mso-list: l2 level1 lfo4; tab-stops: list 18.0pt"><![if !supportLists]><SPAN 
      lang=DE 
      style="mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol; mso-ansi-language: DE"><SPAN 
      style="mso-list: Ignore">·<SPAN 
      style="FONT: 7pt 'Times New Roman'">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 
      </SPAN></SPAN></SPAN><![endif]><SPAN dir=ltr><SPAN lang=DE 
      style="mso-ansi-language: DE">Anand Kumar (Institute for Formal Ontology 
      and Medical Information Science, Saarbrücken, 
      Germany)<o:p></o:p></SPAN></SPAN></P></TD>
  </TR></TBODY></TABLE></DIV>
<P class=MsoNormal style="TEXT-ALIGN: center; mso-outline-level: 1" 
align=center><B style="mso-bidi-font-weight: normal"><SPAN 
style="FONT-SIZE: 16pt"><o:p>&nbsp;</o:p></SPAN></B></P>
<P class=MsoNormal style="TEXT-ALIGN: center; mso-outline-level: 1" 
align=center><B style="mso-bidi-font-weight: normal"><SPAN 
style="FONT-SIZE: 16pt"><o:p>&nbsp;</o:p></SPAN></B></P></DIV></BODY></HTML>
